Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma. Reply

  1. Hungria, V.
  2. Mateos, M.-V.
Revue:
The New England journal of medicine

ISSN: 1533-4406

Année de publication: 2024

Volumen: 391

Número: 14

Pages: 1364-1365

Type: Lettre

DOI: 10.1056/NEJMC2410841 GOOGLE SCHOLAR